SOHONOS
Active substance: palovarotene
CAPSULE · PALOVAROTENE 2.5 mg/1
United StatesActive
Marketing holder: Ipsen Biopharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PALOVAROTENE · 2.5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4925-763f-831c-7e498214d1d0,01a1208e-05fa-73f2-8845-3be61e5cbfb2,01a1208f-910e-713f-b6db-589389f5ed9a,01a12095-7670-77b2-939e-ea8d5893c122,01a1209c-e9ee-7c78-b0c4-4dbf26724683;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 15054-0025
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 15054-0025 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 15054-0025 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 15054-0025 · Verified 2026-10-09 · open in source